Novel insights into astrocyte-mediated signaling of proliferation, invasion and tumor immune microenvironment in glioblastoma

Biomed Pharmacother. 2020 Jun:126:110086. doi: 10.1016/j.biopha.2020.110086. Epub 2020 Mar 12.

Abstract

Glioblastoma (GBM) continues to be the most aggressive cancer of the brain. The dismal prognosis is largely attributed to the microenvironment surrounding tumor cells. Astrocytes, the main component of the GBM microenvironment, play several fundamental physiological roles in the central nervous system. During the development of GBM, tumor-associated astrocytes (TAAs) directly contact GBM cells, which activate astrocytes to form reactive astrocytes, facilitating tumor progression, proliferation and migration through multiple well-understood signaling pathways. Notably, TAAs also influence GBM cell behaviors via suppressing immune responses and enhancing the chemoradiotherapy resistance of tumor cells. These new activities are closely linked with the treatment and prognosis of GBM. In this review, we discuss recent advances regarding new functions of reactive astrocytes, including TAA-cancer cell interactions, mechanisms involved in immunosuppressive regulation, and chemoradiotherapy resistance. It is expected that these updated experimental or clinical studies of TAAs may provide a promising approach for GBM treatment in the near future.

Keywords: Astrocyte; Glioblastoma; Invasion; Microenvironment; Onco-immunology; Proliferation.

Publication types

  • Review

MeSH terms

  • Animals
  • Astrocytes / metabolism*
  • Biobehavioral Sciences
  • Biomarkers
  • Brain Neoplasms / etiology*
  • Brain Neoplasms / metabolism*
  • Brain Neoplasms / pathology
  • Brain Neoplasms / therapy
  • Cell Communication
  • Cell Line, Tumor
  • Cell Movement / genetics
  • Cell Proliferation / genetics
  • Disease Susceptibility
  • Drug Resistance, Neoplasm
  • Energy Metabolism
  • Glioblastoma / etiology*
  • Glioblastoma / metabolism*
  • Glioblastoma / pathology
  • Glioblastoma / therapy
  • Humans
  • Signal Transduction*
  • Tumor Microenvironment* / immunology

Substances

  • Biomarkers